CIK: 901056 - Address: C/o Antares Pharma, Inc., 100 Princeton South, Suite 300, Ewing, NJ 08628
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret1120113205313945
P%wins505010010010010083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/14/20 18:07
1/10/20
ATRSAntares Pharma, Inc.DEHealthMdEqSurgical & Medical InstrumentSamson MarvinNJDM.d02.6600052D
1/14/20 18:07
1/10/20
ATRSAntares Pharma, Inc.DEHealthMdEqSurgical & Medical InstrumentSamson MarvinNJDS.d04.5000052D
1/6/20 18:06
1/2/20
ATRSAntares Pharma, Inc.DEHealthMdEqSurgical & Medical InstrumentSamson MarvinNJDM.d2182.18010052D
1/6/20 18:06
1/2/20
ATRSAntares Pharma, Inc.DEHealthMdEqSurgical & Medical InstrumentSamson MarvinNJDS.d-4594.600-100-6652D
12/26/19 16:57
12/23/19
ATRSAntares Pharma, Inc.DEHealthMdEqSurgical & Medical InstrumentSamson MarvinNJDM.d1681.12015052D
12/26/19 16:57
12/23/19
ATRSAntares Pharma, Inc.DEHealthMdEqSurgical & Medical InstrumentSamson MarvinNJDS.d-7074.710-150-7452D
3/21/16 16:43
3/18/16
ATRSAntares Pharma, Inc.DEHealthMdEqSurgical & Medical InstrumentSamson MarvinNJDP360.720015095103D-82-73-63-44-32-24-19-6-4-8132986277
8/12/14 17:17
8/11/14
ATRSAntares Pharma, Inc.DEHealthMdEqSurgical & Medical InstrumentSamson MarvinNJDP502.003259053D-57-56-55-37-25-10-2-6491311201
1/22/04 20:52
1/20/04
SCRISicor IncDEHealthDrugPharmaceutical PreparationsSamson MarvinOCEOM.d18,66014.6401,2750D
1/22/04 20:52
1/20/04
SCRISicor IncDEHealthDrugPharmaceutical PreparationsSamson MarvinOCEOS.d-35,26027.660-1,275-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact